Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 1090 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial
Mirella Nardo, Camila Braganca Xavier,Bettzy Stephen, Jeffrey A How, Justin Moyers,Vivek Subbiah,David S Hong,Aung Naing
Journal of immunotherapy and precision oncologyno. 2 (2025): 143-151
Cited0Views0WOSBibtex
0
0
Tissue-agnostic Cancer Therapies: Promise, Reality, and the Path Forward
Vivek Subbiah
Nature communicationsno. 1 (2025): 4972-4972
Cited0Views0WOSBibtex
0
0
Surrogate End Points in Oncology: Aligning Drug Development Incentives and Patient Needs
Matthew Vogel,Rona Yaeger, David J Stewart,Vivek Subbiah, Frank S David
Nature reviews Clinical oncology (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 1089

#Citation: 22972

H-Index: 75

G-Index: 131

Sociability: 8

Diversity: 3

Activity: 744

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn